These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2769942

  • 1. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I, Motojima S, Sagara H, Ogata H, Otsuka T, Fukuda T, Ikemori R, Makino S.
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Yoshida M, Ichikawa Y, Kido M, Ninomiya K, Kitahara Y, Hara N, Tsurutani H.
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Efficacy of sulbactam/cefoperazone in respiratory tract infections in elderly patients with underlying respiratory diseases].
    Yoshida T, Oono Y, Toyoda M, Sawa T, Yokoyama H.
    Jpn J Antibiot; 1996 Jul; 49(7):710-4. PubMed ID: 8828072
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K, Horiba M.
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Matsuba K, Yoshida M, Ichikawa Y, Ando M, Matsuzaki Y, Kitahara Y, Hara N.
    Jpn J Antibiot; 1986 Oct; 39(10):2780-94. PubMed ID: 3543433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical experience on sulbactam/cefoperazone in the pediatric field].
    Honjo T, Watanabe A.
    Jpn J Antibiot; 1984 Oct; 37(10):1788-92. PubMed ID: 6094858
    [Abstract] [Full Text] [Related]

  • 13. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, Ueda Y, Kaneko H, Nakao M, Kashima K.
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical study on sulbactam/cefoperazone in the field of pediatrics].
    Minamitani M, Hachimori K, Kaneda K.
    Jpn J Antibiot; 1984 Oct; 37(10):1801-11. PubMed ID: 6094860
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
    Fujii Y, Ayame H, Inoue H, Fujita N, Miyoshi K, Murano K, Hatao K, Yaga K, Kaku K, Kaneko T.
    Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
    Chimura T, Inoue K, Morisaki N.
    Jpn J Antibiot; 1984 Oct; 37(10):1928-33. PubMed ID: 6094871
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
    Meguro H, Tajima T, Nonaka C, Mashiko J, Fujii R, Arimasu O.
    Jpn J Antibiot; 1984 Oct; 37(10):1821-30. PubMed ID: 6094862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.